Mpox: CDC Announces First Administration of Vaccines In Africa

The Afircan Union’s Centres for Disease Control and Prevention (Africa CDC) has announced the first administeration of Mpox vaccines in Africa.

This much was disclosed by a Spokesman for the CDC.

Hundreds of affected persons received the vaccine in Rwanda on Thursday, Neusroom gathered.

The spokesman confirmed that at least 300 doses were administered near Rwandan border with the Democratic Republic of Congo (DRC) on Tuesday.

Africa CDC Director General, Jean Kaseya, confirmed that vaccinations would begin in the DRC in the first week of October.

Last week, the World Health Organization (WHO) endorsed the mpox vaccine, MVA-BN.

This has caused the United Nations and other international agencies to now buy the vaccines in large quantities.

WHO mandates that adults of 18yrs plus can receive two-dose injections of the vaccine in an interval of four weeks.

While mpox fatalities in the DRC have hit children the most, WHO says the vaccine can, otherwise, be used by infants, children, adolescents, pregnant women and those whose immune system’s defenses are low.

“Mpox is not under control,” Kaseya assured.

In areas where supplies of the vaccine are low, WHO says single-doses can suffice.

According to WHO, data shows that a single dose of the MVA-BN vaccine given before exposure had a 76% effectiveness, while two doses have an 82% effect.

“This means vaccine use is recommended in outbreak settings where the benefits of vaccination outweigh the potential risks,” the health organization recently said.

22,000 mpox cases and over 700 deaths linked to the virus have been recorded in the DRC between January and August this year, making it the worst-hit nation in Africa.

Mpox or monkeypox is a virus transmitted to humans by infected animals and can also be passed from human to human based on contact.

Fever and muscular aches are some of the after-effects of this virus.